• Nā huahana
ʻaoʻao

Nā huahana

Hana Kiʻekiʻe Kina Heparin Sodium


  • CAS NO.:9041-08-1
  • HS CODE:3001.9010.00
  • lawelawe waihona:Pākē-GMP, DMF
  • Pharmacopoeia maʻamau:EP/USP
  • Huahana Huahana

    Huahana Huahana

    Ke ho'āʻo nei mākou no ka maikaʻi, hui i nā mea kūʻai aku ", manaʻolana e lilo i hui hui maikaʻi loa a me ka ʻoihana hoʻokele no nā limahana, nā mea hoʻolako a me nā mea kūʻai aku, ʻike i ke kuleana kūpono a me ka hoʻolaha hoʻomau no ka High PerformanceKina Heparin Sodium, ʻAʻole wale mākou e hāʻawi i ka maikaʻi maikaʻi loa i kā mākou mea kūʻai aku, akā ʻoi aku ka mea nui o kā mākou lawelawe nui loa me ke kumukūʻai kūʻai hoʻokūkū.
    Ke hoʻāʻo nei mākou no ka maikaʻi, hui i nā mea kūʻai aku ", manaʻolana e lilo i hui hui maikaʻi loa a me ka ʻoihana dominator no nā limahana, nā mea hoʻolako a me nā mea kūʻai aku, ʻike i ke kuleana kūpono a me ka hoʻolaha hoʻomauKina Heparin Sodium, ʻO ka hauʻoli o ka mea kūʻai aku i kā mākou ʻimi mau, ʻo ka hoʻokumu ʻana i ka waiwai no nā mea kūʻai aku ʻo ia kā mākou kuleana, ʻo ka lōʻihi o ka pili ʻana i ka ʻoihana ʻoihana.He hoa hilinaʻi loa mākou i kāu hihia ma Kina.ʻOiaʻiʻo, hiki ke hāʻawi ʻia nā lawelawe ʻē aʻe, e like me ke kūkākūkā.

    kikoʻī

    1. Nā ʻano: ʻO ka pauka keʻokeʻo a kokoke i ke keʻokeʻo, hygroscopic nui.

    2. Puna: Puka ʻōpū mucosa.

    3. Ke Kaʻina Hana: Hoʻopuka ʻia ka sodium Heparin mai ka mucosa o ka ʻōpū puaʻa olakino.

    4. Nā hōʻailona a me ka hoʻohana ʻana: Hoʻohana nui ʻia kēia huahana no ka pale ʻana i ka maʻi thromboembolic, ʻoi aku ka maikaʻi no ka pono o ka anticoagulant wikiwiki, e like me: 1. Acute a maʻi venous thrombosis a ʻaʻohe hoʻololi koʻikoʻi kahe koko o ka pulmonary embolism (PE). Heparin Hiki iā ia ke ho'ōki i ka hoʻonui ʻana o ka embolus e hoʻolōʻihi i ka manawa no ka thrombolysis o ke kino.2. Kāohi a mālama ʻana i ka fibrillation Atrial me ka embolism.3. Hoʻomaʻamaʻa ʻana i ka coagulation intravascular diffuse mua (DIC).4. Ka pale ʻana a me ka mālama ʻana i ka thrombosis arterial peripheral a i ʻole myocardial infarction.5. ʻO nā mea ʻē aʻe in vitro anticoagulation: e like me ka ʻoki cardiovascular, in vitro circulation, hemodialysis, angiography, hiki ke hoʻohana ʻia no ka transfusion a i ʻole ka hoʻomākaukau ʻana i ke koko, i kēia manawa nā hōʻailona nui o ka noi heparin he thrombosis vein hohonu (DVT), PE a me ka thrombosis i nā maʻi pilikia nui.

    img (2)
    img (3)

    No ke aha mākou?

    · Ua hala i ka GMP Kina

    · 27 makahiki o ka moʻolelo R&D biological enzyme

    · Hiki ke ʻimi ʻia nā mea maka

    · E hoʻokō me USP, EP a me ka mea kūʻai maʻamau

    · Hoʻokuʻu aku i 30 mau ʻāina a me nā ʻāina

    · Loaʻa ka mana o ka hoʻokele ʻōnaehana maikaʻi e like me US FDA, Japan PMDA, South Korea MFDS, etc.

    Hōʻike

    Nā mea ho'āʻo

    Hōʻikeʻike Hui

    EP

    USP

    Nā huaʻōlelo

    ʻO ka pauka keʻokeʻo a aneane keʻokeʻo paha, hygroscopic nui

    ʻIkepili

    Thrombotest: Kūlike

    ʻIkepili Chromatographic: Kūlike

    1H NMR Spectrum: Kūlike

    1H NMR Spectrum: Kūlike

    Kromatography Liquid: Kūlike

    Kaumaha-awelika molecular kaumaha: 15000~19000

    Sodium: Kūlike

    Sodium: Kūlike

    Anati-factor Xa i anti-factor IIa ratio:0.9~1.1

    Anati-factor Xa i anti-factor IIa ratio:0.9~1.1

    Nā hoʻāʻo

    Ka malamalama a me ke kala

    Mākaʻikaʻi: Akaka, kala: e 5 a ʻoi aku paha

    ————

    Nitrogen

    1.5~2.5%(mea maloʻo)

    1.3~2.5%(mea maloʻo)

    Nucleotidic haumia

    A260≤ 0.15(4mg/ml)

    ≤ 0.1(w/w)

    Nā mea pili

    Kūlike

    ————

    Ka palena o ka galactosamine i ka huina hexosamine

    ————

    ≤ 1.0%

    Oversulfated chondroitin sulfate

    ————

    Kūlike

    pH

    5.5~8.0(1%)

    5.5~7.5(1%)

    Pohō ma ka maloʻo

    ≤ 8.0%(60 ℃ Maloo i ka Mūmā, 3h)

    ≤ 5.0%(60 ℃ Maloo i ka Mūmā, 3h)

    Ke koena ma ka ʻā

    ————

    28.0%~41.0%

    Endotoxin bacteria

    ≤ 0.01 IU/Hui Hui Pū ʻIa o Heparin

    ≤ 0.03 USP U/Wāhi Mokupuni o Heparin

    Metala kaumaha

    ≤ 30ppm

    ≤ 30ppm

    Sodium

    10.5~13.5%(mea maloʻo)

    ————

    Pākīpika

    ≤ 0.5% (mea maloʻo)

    ≤ 0.1%(Lakiona kaumaha)

    Ka hana

    ≥ 180 IU/mg (mea maloʻo)

    ≥ 180 USP U/mg (mea maloʻo)

    ʻO nā meaʻeleʻele microbial

    TAMC

    ≤ 1000cfu/g

    ≤ 1000cfu/g

    TYMC

    ≤ 100cfu/g

    ≤ 100cfu/g

    E.coli

    Kūlike

    Kūlike

    ʻO Staphylococcus aureus

    Kūlike

    Kūlike

    Salmonella

    Kūlike

    Kūlike

    Ke ho'āʻo nei mākou no ka maikaʻi, hui i nā mea kūʻai aku ", manaʻolana e lilo i hui hui maikaʻi loa a me ka ʻoihana hoʻokele no nā limahana, nā mea hoʻolako a me nā mea kūʻai aku, ʻike i ke kuleana kūpono a me ka hoʻolaha hoʻomau no ka High PerformanceKina Heparin SodiumʻAʻole wale mākou e hāʻawi i ka maikaʻi ʻoi aku ka maikaʻi i kā mākou mea kūʻai aku, akā ʻoi aku ka mea nui o kā mākou lawelawe ʻoi loa me ke kumukūʻai kūʻai hoʻokūkū.
    High Performance Kina Heparin, Customer ka hauʻoli mau i kā mākou imi, hana waiwai no nā mea kūʻai mai i mau ko makou hana, he lōʻihi manawa like-pono pāʻoihana pili ka mea a mākou e hana nei.He hoa hilinaʻi loa mākou i kāu hihia ma Kina.ʻOiaʻiʻo, hiki ke hāʻawi ʻia nā lawelawe ʻē aʻe, e like me ke kūkākūkā.


  • Mua:
  • Aʻe:

  • E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou
    AEO
    EHS
    EU-GMP
    GMP
    HACCP
    ISO
    Paʻi
    PMDA
    hoa_mua
    hoa_next
    Huahana wela - Palapala kahua - AMP Mobile